Table 2. PFAS Concentrations in the Cord Blood (ng/mL) in the Whole Cohort and in Mothers Whose Children Did Not Develop Autoimmune Diseases during the Follow-Up Period (18 Years) and in Mothers Whose Children Developed Autoimmune Diseases.
maternal group | PFDA | PFHxS | PFOA | PFOA_Br | PFOS | PFOS_Br | PFTrDA | |
---|---|---|---|---|---|---|---|---|
All | MEDIAN | 0.08 | 0.11 | 0.57 | 2.20 | 1.71 | 3.02 | 0 |
MIN | <LOQ | <LOQ | 0.07 | 0.40 | 0.81 | 1.39 | <LOQ | |
MAX | 0.13 | 23.65 | 3.04 | 6.96 | 16.85 | 33.21 | 0.04 | |
CTRL | MED | 0.08 | 0.06 | 0.67 | 2.66 | 1.90 | 3.47 | 0 |
MIN | <LOQ | <LOQ | <LOQ | <LOQ | 0.38 | 0.68 | <LOQ | |
MAX | 0.20 | 66.59 | 4.59 | 13.06 | 40.74 | 74.17 | 0.04 | |
CASES | MED | 0.08 | 0.11 | 0.56 | 2.21 | 1.71 | 3.06 | 0.01 |
MIN | <LOQ | <LOQ | 0.07 | 0.40 | 0.81 | 1.39 | <LOQ | |
MAX | 0.13 | 23.65 | 3.04 | 6.96 | 16.85 | 33.21 | 0.04 |